Monoclonal gammopathy and myeloproliferative neoplasm molecular diagnostics
Stephen E. Langabeer
doaj +1 more source
Case Report: Myelodysplastic/myeloproliferative neoplasm with concurrent SF3B1, ASXL1, JAK2 and CBL mutations and <15% bone marrow ringed sideroblasts. [PDF]
Wang Y, Jin S.
europepmc +1 more source
Impact of age and time since diagnosis on thrombosis risk in myeloproliferative neoplasm patients: A nationwide register-based matched cohort study. [PDF]
Batyrbekova N +6 more
europepmc +1 more source
TP53-Mutated Acute Myeloid Leukemia and Blast Phase Myeloproliferative Neoplasm: Distinct Mutation Leads to Poorer Prognosis. [PDF]
Chen D, Cantu M, Siddon A, Weinberg OK.
europepmc +1 more source
Latent JAK2 V617F-Positive Myeloproliferative Neoplasm With Normal Blood Counts and Recurrent Splanchnic Vein Thrombosis in a Young Woman. [PDF]
Thida AM +4 more
europepmc +1 more source
Optimizing Care: Integrative Oncology in Myeloproliferative Neoplasm. [PDF]
Singh S, Peshin S, Larsen A, Gowin K.
europepmc +1 more source
Differential regulation of mTORC2 signalling by type I and type II calreticulin (CALR) driver mutations of myeloproliferative neoplasm. [PDF]
Naseer S +6 more
europepmc +1 more source
Shaping the Future of Myeloproliferative Neoplasm Therapy: Immune-Based Strategies and Targeted Innovations. [PDF]
Carturan A +4 more
europepmc +1 more source
Molecular Profile of BCR-ABL1 Negative Myeloproliferative Neoplasm in a Moroccan Population. [PDF]
Soro SGC +9 more
europepmc +1 more source
Classification and Prognostic Stratification Based on Genomic Features in Myelodysplastic and Myeloproliferative Neoplasm- and Their Overlapping Conditions. [PDF]
Lee JM +17 more
europepmc +1 more source

